直接経口抗凝固薬（DOAC）デバイス市場、規模、シェア、動向、産業分析レポート：製品タイプ別、疾患適応症別、用途別、患者層別、エンドユーザー別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、直接経口抗凝固薬（DOAC）デバイス市場規模は2034年までに648億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

直接経口抗凝固薬（DOAC）デバイスは、直接経口抗凝固薬を使用する患者の抗凝固レベルを監視し、安全で効果的な治療成果を確保するために設計された特殊な診断ツールです。これらのデバイスは、特に脳卒中予防、静脈血栓塞栓症管理、術後治療において、凝固状態を正確かつリアルタイムに把握することにより、臨床的意思決定において重要な役割を果たします。

凝固検査は、治療の精度を高め、有害事象を最小限に抑え、病院、外来センター、在宅医療のあらゆる場面で患者の個別ケアをサポートするために不可欠です。アッセイ感度、デバイスの携帯性、デジタル接続性の進歩により、診断効率が向上し、急性期と慢性期の両方のケア経路におけるこれらのシステムの有用性が拡大しています。日常的な臨床ワークフローへの統合は、患者の転帰の改善、モニタリングの合理化、全体的なヘルスケアコストの最適化に寄与します。

直接経口抗凝固薬（DOAC）デバイス市場レポートハイライト

用途別では、主に心房細動や抗凝固療法を必要とするその他の心血管疾患の有病率が上昇していることから、脳卒中予防分野が2024年の市場をリードしました。

エンドユーザー別では、病院が急性血栓イベントと慢性抗凝固療法の両方を包括的に管理する主要なヘルスケア施設として機能していることから、予測期間中に最も高いCAGRを記録すると予測されます。

北米は、洗練されたヘルスケア・インフラ、高い血栓塞栓性疾患負担、医療環境全体における直接経口抗凝固薬の広範な臨床採用により、2024年のDOACデバイス市場で最大の売上シェアを獲得しました。

アジア太平洋市場は、医療費の増加、凝固障害に対する意識の高まり、予防医療や個別化治療への移行が進んでいることを背景に、安定した成長が見込まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の直接経口抗凝固薬（DOAC）デバイス市場の洞察

• 市場スナップショット
• 直接経口抗凝固薬（DOAC）デバイス市場力学
  • 促進要因と機会
    • 血栓塞栓症の世界的負担の増大
    • 高齢化が進む世界人口、心血管疾患リスクが高め
  • 抑制要因と課題
    • 高度な診断装置の高コスト
• PESTEL分析
• 直接経口抗凝固薬（DOAC）デバイス市場の動向
• バリューチェーン分析

第5章 世界の直接経口抗凝固薬（DOAC）デバイス市場：製品タイプ別

• 主な調査結果
• イントロダクション
• 因子Xa阻害剤
• 直接トロンビン阻害剤

第6章 世界の直接経口抗凝固薬（DOAC）デバイス市場：疾患適応症別

• 主な調査結果
• イントロダクション
• 心房細動
• 深部静脈血栓症（DVT）
• 肺塞栓症（PE）
• 心臓発作
• 術後血栓予防
• その他

第7章 世界の直接経口抗凝固薬（DOAC）デバイス市場：用途別

• 主な調査結果
• イントロダクション
• 脳卒中予防
• 静脈血栓塞栓症の予防
• 急性血栓症の治療
• 長期予防
• その他の用途

第8章 世界の直接経口抗凝固薬（DOAC）デバイス市場：患者層別

• 主な調査結果
• イントロダクション
• 小児
• 成人
• 高齢者

第9章 世界の直接経口抗凝固薬（DOAC）デバイス市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 病院
• 外来手術センター
• 専門クリニック
• 在宅ケア環境
• その他

第10章 世界の直接経口抗凝固薬（DOAC）デバイス市場：地域別

• 主な調査結果
• イントロダクション
  • 直接経口抗凝固薬（DOAC）デバイス市場評価：地域別、2020年～2034年
• 北米
  • 北米：製品タイプ別、2020～2034年
  • 北米：疾患別、2020～2034年
  • 北米：用途別、2020～2034年
  • 北米：患者層別、2020～2034年
  • 北米：エンドユーザー別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品タイプ別、2020～2034年
  • 欧州：疾患別、2020～2034年
  • 欧州：用途別、2020～2034年
  • 欧州：患者層別、2020～2034年
  • 欧州：エンドユーザー別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：製品タイプ別、2020～2034年
  • アジア太平洋地域：疾患別、2020年～2034年
  • アジア太平洋地域：用途別、2020～2034年
  • アジア太平洋地域：患者層別、2020～2034年
  • アジア太平洋地域：エンドユーザー別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品タイプ別、2020～2034年
  • 中東・アフリカ：疾患別、2020年～2034年
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：患者層別、2020～2034年
  • 中東・アフリカ：エンドユーザー別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品タイプ別、2020-2034年
  • ラテンアメリカ：疾患別、2020年～2034年
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：患者層別、2020～2034年
  • ラテンアメリカ：エンドユーザー別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第11章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第12章 企業プロファイル

• Siemens Healthineers
• Abbott Laboratories
• Roche Diagnostics
• Sysmex Corporation
• Instrumentation Laboratory（Werfen）
• Nihon Kohden Corporation
• Diagnostica Stago
• Coag-Sense
• HemoSonics
• Sekisui Medical Co., Ltd.
• Grifols S.A.
• Helena Laboratories Corporation

List of Tables:

• Table 1 Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 2 Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 3 Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 4 Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 5 Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 6 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 7 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 8 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 9 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 10 North America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 11 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 12 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 13 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 14 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 15 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 16 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 17 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 18 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 19 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 20 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 21 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 22 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 23 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 24 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 25 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 26 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 27 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 28 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 29 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 30 UK: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 31 France: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 32 France: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 33 France: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 34 France: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 35 France: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 36 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 37 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 38 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 39 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 40 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 41 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 42 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 43 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 44 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 45 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 46 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 47 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 48 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 49 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 50 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 51 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 52 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 53 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 54 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 55 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 56 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 57 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 58 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 59 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 60 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 61 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 62 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 63 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 64 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 65 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 66 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 67 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 68 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 69 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 70 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 71 China: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 72 China: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 73 China: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 74 China: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 75 China: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 76 India: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 77 India: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 78 India: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 79 India: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 80 India: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 81 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 82 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 83 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 84 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 85 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 86 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 87 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 88 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 89 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 90 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 91 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 92 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 93 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 94 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 95 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 96 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 97 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 98 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 99 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 100 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 101 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 102 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 103 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 104 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 105 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 106 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 107 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 108 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 109 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 110 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 111 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 112 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 113 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 114 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 115 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 116 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 117 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 118 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 119 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 120 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 121 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 122 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 123 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 124 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 125 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 126 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 127 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 128 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 129 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 130 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 131 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 132 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 133 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 134 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 135 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 136 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 137 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 138 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 139 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 140 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 141 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 142 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 143 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 144 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 145 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 146 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 147 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 148 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 149 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 150 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 151 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 152 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 153 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 154 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 155 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 156 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 157 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 158 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 159 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 160 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• Table 161 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• Table 162 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• Table 163 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• Table 164 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• Table 165 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Direct Oral Anticoagulants (DOACs) Device Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product Type
• Figure 7. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Disease Indication
• Figure 9. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2024 & 2034 (USD Billion)
• Figure 10. Market by Application
• Figure 11. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2024 & 2034 (USD Billion)
• Figure 12. Market by Patient Demographic
• Figure 13. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2024 & 2034 (USD Billion)
• Figure 14. Market by End User
• Figure 15. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2024 & 2034 (USD Billion)

The direct oral anticoagulants device market size is expected to reach USD 64.83 Billion by 2034, according to a new study by Polaris Market Research. The report "Direct Oral Anticoagulants (DOACs) Device Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Disease Indication, By Application, By Patient Demographic, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Direct Oral Anticoagulants (DOACs) Device coagulation devices are specialized diagnostic tools designed to monitor anticoagulation levels in patients using direct oral anticoagulants, ensuring safe and effective therapeutic outcomes. These devices play a critical role in clinical decision-making by providing accurate, real-time insights into coagulation status, particularly in stroke prevention, venous thromboembolism management, and post-surgical care.

They are essential for improving treatment precision, minimizing adverse events, and supporting individualized patient care across hospitals, ambulatory centers, and homecare settings. Advancements in assay sensitivity, device portability, and digital connectivity are enhancing diagnostic efficiency and expanding the utility of these systems in both acute and chronic care pathways. Their integration into routine clinical workflows contributes to better patient outcomes, streamlined monitoring, and overall healthcare cost optimization.

Direct Oral Anticoagulants (DOACs) Device Market Report Highlights

In terms of application, the stroke prevention segment led the market in 2024, primarily due to rising prevalence of atrial fibrillation and other cardiovascular conditions requiring anticoagulation therapy.

In terms of end user, the hospitals are expected to register the highest CAGR during the forecast period, as they serve as the primary healthcare setting for comprehensive management of both acute thrombotic events and chronic anticoagulation requirements.

North America captured the largest revenue share in the DOAC device market in 2024, owing to its sophisticated healthcare infrastructure, high thromboembolic disease burden, and widespread clinical adoption of direct oral anticoagulants across care settings.

The Asia Pacific market is anticipated to demonstrate consistent growth, fueled by increasing healthcare expenditure, greater awareness of coagulation disorders, and a progressive transition toward preventive care and personalized treatment approaches.

A few global key market players include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Instrumentation Laboratory (Werfen), Nihon Kohden Corporation, Diagnostica Stago, Coag-Sense, HemoSonics, Sekisui Medical Co., Ltd., Grifols S.A., and Helena Laboratories Corporation.

Polaris Market Research has segmented the market report on the basis of product type, disease indication, application, patient demographic, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

Factor Xa Inhibitors

Direct Thrombin Inhibitors

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Atrial Fibrillation

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Heart Attacks

Post-Surgical Thromboprophylaxis

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Stroke Prevention

Venous Thromboembolism Prevention

Treatment of Acute Thrombotic Events

Long-Term Prophylaxis

Other Application

By Patient Demographic Outlook (Revenue, USD Billion, 2020-2034)

Paediatric

Adult

Geriatric

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Homecare Settings

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Direct Oral Anticoagulants (DOACs) Device Market Insights

• 4.1. Direct Oral Anticoagulants (DOACs) Device Market - Market Snapshot
• 4.2. Direct Oral Anticoagulants (DOACs) Device Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Global Burden of Thromboembolic Disorders
    • 4.2.1.2. Aging Global Population with High Cardiovascular Risk
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Cost of Advanced Diagnostic Devices
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Direct Oral Anticoagulants (DOACs) Device Market Trends
• 4.6. Value Chain Analysis

5. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
• 5.3. Factor Xa Inhibitors
  • 5.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Factor Xa Inhibitors, by Region, 2020-2034 (USD Billion)
• 5.4. Direct Thrombin Inhibitors
  • 5.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Direct Thrombin Inhibitors, by Region, 2020-2034 (USD Billion)

6. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
• 6.3. Atrial Fibrillation
  • 6.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Atrial Fibrillation, by Region, 2020-2034 (USD Billion)
• 6.4. Deep Vein Thrombosis (DVT)
  • 6.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Deep Vein Thrombosis (DVT), by Region, 2020-2034 (USD Billion)
• 6.5. Pulmonary Embolism (PE)
  • 6.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Pulmonary Embolism (PE), by Region, 2020-2034 (USD Billion)
• 6.6. Heart Attacks
  • 6.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Heart Attacks, by Region, 2020-2034 (USD Billion)
• 6.7. Post-Surgical Thromboprophylaxis
  • 6.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Post-Surgical Thromboprophylaxis, by Region, 2020-2034 (USD Billion)
• 6.8. Others
  • 6.8.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
• 7.3. Stroke Prevention
  • 7.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Stroke Prevention, by Region, 2020-2034 (USD Billion)
• 7.4. Venous Thromboembolism Prevention
  • 7.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Venous Thromboembolism Prevention, by Region, 2020-2034 (USD Billion)
• 7.5. Treatment of Acute Thrombotic Events
  • 7.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Treatment of Acute Thrombotic Events, by Region, 2020-2034 (USD Billion)
• 7.6. Long-Term Prophylaxis
  • 7.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Long-Term Prophylaxis, by Region, 2020-2034 (USD Billion)
• 7.7. Other Application
  • 7.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Other Application, by Region, 2020-2034 (USD Billion)

8. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
• 8.3. Paediatric
  • 8.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Paediatric, by Region, 2020-2034 (USD Billion)
• 8.4. Adult
  • 8.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Adult, by Region, 2020-2034 (USD Billion)
• 8.5. Geriatric
  • 8.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geriatric, by Region, 2020-2034 (USD Billion)

9. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• 9.3. Hospitals
  • 9.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 9.4. Ambulatory Surgical Centers
  • 9.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
• 9.5. Specialty Clinics
  • 9.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
• 9.6. Homecare Settings
  • 9.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)
• 9.7. Others
  • 9.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Direct Oral Anticoagulants (DOACs) Device Market Assessment, By Geography, 2020-2034 (USD Billion)
• 10.3. Direct Oral Anticoagulants (DOACs) Device Market - North America
  • 10.3.1. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 10.3.2. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.3.3. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 10.3.4. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 10.3.5. North America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.3.6. Direct Oral Anticoagulants (DOACs) Device Market - U.S.
    • 10.3.6.1. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.3.6.2. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.6.3. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6.4. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.3.6.5. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.3.7. Direct Oral Anticoagulants (DOACs) Device Market - Canada
    • 10.3.7.1. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.3.7.2. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.7.3. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7.4. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.3.7.5. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• 10.4. Direct Oral Anticoagulants (DOACs) Device Market - Europe
  • 10.4.1. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 10.4.2. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.4.3. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 10.4.4. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 10.4.5. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.6. Direct Oral Anticoagulants (DOACs) Device Market - UK
    • 10.4.6.1. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.6.2. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.6.3. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6.4. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.6.5. UK: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.7. Direct Oral Anticoagulants (DOACs) Device Market - France
    • 10.4.7.1. France: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.7.2. France: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.7.3. France: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7.4. France: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.7.5. France: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.8. Direct Oral Anticoagulants (DOACs) Device Market - Germany
    • 10.4.8.1. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.8.2. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.8.3. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8.4. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.8.5. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.9. Direct Oral Anticoagulants (DOACs) Device Market - Italy
    • 10.4.9.1. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.9.2. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.9.3. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9.4. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.9.5. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.10. Direct Oral Anticoagulants (DOACs) Device Market - Spain
    • 10.4.10.1. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.10.2. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.10.3. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10.4. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.10.5. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.11. Direct Oral Anticoagulants (DOACs) Device Market - Netherlands
    • 10.4.11.1. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.11.2. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.11.3. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11.4. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.11.5. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.12. Direct Oral Anticoagulants (DOACs) Device Market - Russia
    • 10.4.12.1. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.12.2. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.12.3. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12.4. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.12.5. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.13.2. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.13.3. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13.4. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.13.5. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• 10.5. Direct Oral Anticoagulants (DOACs) Device Market - Asia Pacific
  • 10.5.1. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 10.5.2. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.5.3. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 10.5.4. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 10.5.5. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.6. Direct Oral Anticoagulants (DOACs) Device Market - China
    • 10.5.6.1. China: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.6.2. China: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.6.3. China: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6.4. China: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.6.5. China: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.7. Direct Oral Anticoagulants (DOACs) Device Market - India
    • 10.5.7.1. India: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.7.2. India: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.7.3. India: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7.4. India: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.7.5. India: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.8. Direct Oral Anticoagulants (DOACs) Device Market - Malaysia
    • 10.5.8.1. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.8.2. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.8.3. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8.4. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.8.5. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.9. Direct Oral Anticoagulants (DOACs) Device Market - Japan
    • 10.5.9.1. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.9.2. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.9.3. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9.4. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.9.5. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.10. Direct Oral Anticoagulants (DOACs) Device Market - Indonesia
    • 10.5.10.1. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.10.2. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.10.3. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10.4. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.10.5. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.11. Direct Oral Anticoagulants (DOACs) Device Market - South Korea
    • 10.5.11.1. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.11.2. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.11.3. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11.4. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.11.5. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.12. Direct Oral Anticoagulants (DOACs) Device Market - Australia
    • 10.5.12.1. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.12.2. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.12.3. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12.4. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.12.5. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.13.2. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.13.3. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13.4. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.13.5. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• 10.6. Direct Oral Anticoagulants (DOACs) Device Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 10.6.2. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.6.3. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 10.6.4. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 10.6.5. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6.6. Direct Oral Anticoagulants (DOACs) Device Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.6.2. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.6.3. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6.4. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.6.5. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6.7. Direct Oral Anticoagulants (DOACs) Device Market - UAE
    • 10.6.7.1. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.7.2. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.7.3. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7.4. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.7.5. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6.8. Direct Oral Anticoagulants (DOACs) Device Market - Israel
    • 10.6.8.1. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.8.2. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.8.3. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8.4. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.8.5. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6.9. Direct Oral Anticoagulants (DOACs) Device Market - South Africa
    • 10.6.9.1. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.9.2. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.9.3. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9.4. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.9.5. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6.10. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.10.2. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.10.3. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10.4. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.10.5. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
• 10.7. Direct Oral Anticoagulants (DOACs) Device Market - Latin America
  • 10.7.1. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 10.7.2. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.7.3. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 10.7.4. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 10.7.5. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.7.6. Direct Oral Anticoagulants (DOACs) Device Market - Mexico
    • 10.7.6.1. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.7.6.2. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.6.3. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6.4. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.7.6.5. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.7.7. Direct Oral Anticoagulants (DOACs) Device Market - Brazil
    • 10.7.7.1. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.7.7.2. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.7.3. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7.4. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.7.7.5. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.7.8. Direct Oral Anticoagulants (DOACs) Device Market - Argentina
    • 10.7.8.1. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.7.8.2. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.8.3. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8.4. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.7.8.5. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.7.9. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.7.9.2. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.9.3. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9.4. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.7.9.5. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. Siemens Healthineers
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Abbott Laboratories
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Roche Diagnostics
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Sysmex Corporation
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. Instrumentation Laboratory (Werfen)
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Nihon Kohden Corporation
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. Diagnostica Stago
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Coag-Sense
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. HemoSonics
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Sekisui Medical Co., Ltd.
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. Grifols S.A.
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development
• 12.12. Helena Laboratories Corporation
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Benchmarking
  • 12.12.4. Recent Development